A unique plasma microRNA profile defines type 2 diabetes progression

Area of Science:

• Biochemistry
• Molecular Biology
• Endocrinology

Background:

• Type 2 Diabetes (T2D) management requires better prediction methods for individuals with glucose dysmetabolism.
• Early identification of pre-diabetic individuals who will progress to T2D is a significant unmet medical need.

Purpose of the Study:

• To investigate the potential of plasma circulating microRNAs for predicting T2D progression.
• To identify specific microRNA signatures associated with different glucose tolerance statuses.

Main Methods:

• Retrospective analysis of plasma microRNA levels in subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT) (progressors and non-progressors), and newly diagnosed T2D.
• Quantification of circulating microRNAs using molecular techniques.

Main Results:

• Impaired glucose tolerance showed a global increase in plasma microRNAs.
• Specific microRNAs (miR-148, miR-222) were modulated in T2D and correlated with glucose tolerance.
• Non-progressing IGT subjects exhibited the most significant microRNA dysregulation, with unique profiles including altered miR-122, miR-99, let-7d, and others.
• Several dysregulated microRNAs correlated with cholesterol metabolism parameters.

Conclusions:

• Plasma microRNA profiles are significantly perturbed in pre-diabetic subjects, especially non-progressors.
• A unique microRNA signature in non-progressing IGT individuals may aid in predicting T2D development.
• MicroRNA analysis holds promise for early T2D risk assessment.